Comparison between on-demand dosing of dapoxetine alone and dapoxetine plus mirodenafil in patients with lifelong premature ejaculation: Prospective, randomized, double-blind, placebo-controlled, multicenter study

Journal of Sexual Medicine

Volumn 10, Issue 11, 2013, Pages 2832-2841

  Lee, Won Ki ^a   Lee, Seong Ho ^a   Cho, Sung Tae ^b   Lee, Yong Sung ^c   Oh, Cheol Young ^a   Yoo, Changhee ^a   Cho, Jin Seon ^a   Lee, Sang Kon ^a   Yang, Dae Yul ^d  

^a Hallym University   (South Korea)

^b Kangnam Sacred Heart Hospital   (South Korea)

^c Hangang Sacred Heart Hospital   (South Korea)

^d Kangdong Sacred Heart Hospital   (South Korea)

Author keywords

Dapoxetine; Intravaginal Ejaculatory Latency Time; Mirodenafil; Premature Ejaculation

Indexed keywords

DAPOXETINE; MIRODENAFIL; PLACEBO;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; ERECTILE DYSFUNCTION; FOREPLAY; HUMAN; INTERNATIONAL INDEX OF ERECTILE FUNCTION; LATENT PERIOD; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; PHYSICAL EXAMINATION; PREMATURE EJACULATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; SEXUAL DYSFUNCTION; SEXUAL INTERCOURSE; VITAL SIGN;

DAPOXETINE; INTRAVAGINAL EJACULATORY LATENCY TIME; MIRODENAFIL; PREMATURE EJACULATION;

ADULT; AGED; BENZYLAMINES; DOUBLE-BLIND METHOD; HUMANS; MALE; MIDDLE AGED; NAPHTHALENES; PHOSPHODIESTERASE 5 INHIBITORS; PLACEBOS; PREMATURE EJACULATION; PROSPECTIVE STUDIES; PYRIMIDINONES; SEROTONIN UPTAKE INHIBITORS; SULFONAMIDES; TREATMENT OUTCOME;

EID: 84887111343     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/jsm.12287     Document Type: Article

References (44)

1. Althof SE, Abdo CH, Dean J, Hackett G, McCabe M, McMahon CG, Rosen RC, Sadovsky R, Waldinger M, Becher E, Broderick GA, Buvat J, Goldstein I, El-Meliegy AI, Giuliano F, Hellstrom WJ, Incrocci L, Jannini EA, Park K, Parish S, Porst H, Rowland D, Segraves R, Sharlip I, Simonelli C, Tan HM. International Society for Sexual Medicine's guidelines for the diagnosis and treatment of premature ejaculation. J Sex Med 2010;7:2947-2969.
2. Porst H. An overview of pharmacotherapy in premature ejaculation. J Sex Med 2011;8(suppl 4):335-341.
3. McMahon CG, Porst H. Oral agents for the treatment of premature ejaculation: Review of efficacy and safety in the context of the recent International Society for Sexual Medicine criteria for lifelong premature ejaculation. J Sex Med 2011;8:2707-2725.
4. Hatzimouratidis K, Amar E, Eardley I, Giuliano F, Hatzichristou D, Montorsi F, Vardi Y, Wespes E. Guidelines on male sexual dysfunction: Erectile dysfunction and premature ejaculation. Eur Urol 2010;57:804-814.
5. Abdel-Hamid IA, Jannini EA, Andersson KE. Premature ejaculation: Focus on therapeutic targets. Expert Opin Ther Targets 2009;13:175-193.
6. Asimakopoulos AD, Miano R, Finazzi Agrò E, Vespasiani G, Spera E. Does current scientific and clinical evidence support the use of phosphodiesterase type 5 inhibitors for the treatment of premature ejaculation? A systematic review and meta-analysis. J Sex Med 2012;9:2404-2416.
7. Aversa A, Pili M, Francomano D, Bruzziches R, Spera E, La Pera G, Spera G. Effects of vardenafil administration on intravaginal ejaculatory latency time in men with lifelong premature ejaculation. Int J Impot Res 2009;21:221-227.
8. Mathers MJ, Klotz T, Roth S, Lummen G, Sommer F. Safety and efficacy of vardenafil versus sertraline in the treatment of premature ejaculation: A randomised, prospective and crossover study. Andrologia 2009;41:169-175.
9. Mattos RM, Marmo Lucon A, Srougi M. Tadalafil and fluoxetine in premature ejaculation: Prospective, randomized, double-blind, placebo-controlled study. Urol Int 2008;80:162-165.
10. Gokce A, Halis F, Demirtas A, Ekmekcioglu O. The effects of three phosphodiesterase type 5 inhibitors on ejaculation latency time in lifelong premature ejaculators: A double-blind laboratory setting study. BJU Int 2010;107:1274-1277.
11. Paick JS, Ahn TY, Choi HK, Chung WS, Kim JJ, Kim SC, Kim SW, Lee SW, Min KS, Moon KH, Park JK, Park K, Park NC, Suh JK, Yang DY, Jung HG. Efficacy and safety of mirodenafil, a new oral phosphodiesterase type 5 inhibitor, for treatment of erectile dysfunction. J Sex Med 2008;5:2672-2680.
12. Dresser MJ, Desai D, Gidwani S, Seftel AD, Modi NB. Dapoxetine, a novel treatment for premature ejaculation, does not have pharmacokinetic interactions with phosphodiesterase-5 inhibitors. Int J Impot Res 2006;18:104-110.
13. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th edition. Washington, DC: American Psychiatric Association; 2000.
14. Hwang I, Yang DO, Park K. Self-reported prevalence of and attitudes toward premature ejaculation in a community-based study of married couples. World J Mens Health 2013;31:70-75.
15. Cappelleri JC, Rosen RC, Smith MD, Mishra A, Osterloh IH. Diagnostic evaluation of the erectile function domain of the International Index of Erectile Function. Urology 1999;54:346-351.
16. Rosen R, McMahon C, Niederberger C, Broderick G, Jamieson C, Gagnon DD. Correlates to the clinical diagnosis of premature ejaculation: Results from a large observational study of men and their partners. J Urol 2007;177:1059-1064.
17. McMahon C. Clinical trial methodology in premature ejaculation observational, interventional and treatment preference studies-Part 1-Defining and selecting the study population. J Sex Med 2008;6:1805-1816.
18. Patrick DL, Giuliano F, Ho KF, Gagnon DD, McNulty P, Rothman M. The Premature Ejaculation Profile: Validation of self-reported outcome measures for research and practice. BJU Int 2009;103:358-364.
19. Aversa A, Francomano D, Bruzziches R, Natali M, Spera G, Lenzi A. Is there a role for phosphodiesterase type-5 inhibitors in the treatment of premature ejaculation? Int J Impot Res 2011;23:17-23.
20. Waldinger MD, Zwinderman AH, Olivier B, Schweitzer DH. Geometric mean IELT and premature ejaculation: Appropriate statistics to avoid overestimation of treatment efficacy. J Sex Med 2008;5:492-499.
21. Jannini EA, Lombardo F, Lenzi A. Correlation between ejaculatory and erectile dysfunction. Int J Androl 2005;28(suppl 2):40-45.
22. McMahon CG, McMahon CN, Leow LJ, Winestock CG. Efficacy of type-5 phosphodiesterase inhibitors in the drug treatment of premature ejaculation: A systematic review. BJU Int 2006;98:259-272.
23. Jannini EA, McMahon C, Chen J, Aversa A, Perelman M. The controversial role of phosphodiesterase type 5 inhibitors in the treatment of premature ejaculation. J Sex Med 2011;8:2135-2143.
24. Mancina R, Filippi S, Marini M, Morelli A, Vignozzi L, Salonia A, Montorsi F, Mondaini N, Vannelli GB, Donati S, Lotti F, Forti G, Maggi M. Expression and functional activity of phosphodiesterase type 5 in human and rabbit vas deferens. Mol Hum Reprod 2005;11:107-115.
25. Uckert S, Oelke M, Stief CG, Andersson KE, Jonas U, Hedlund P. Immunohistochemical distribution of cAMP- and cGMP-phosphodiesterase (PDE) isoenzymes in the human prostate. Eur Urol 2006;49:740-745.
26. Medina P, Segarra G, Torondel B, Chuan P, Domenech C, Vila JM, Lluch S. Inhibition of neuroeffector transmission in human vas deferens by sildenafil. Br J Pharmacol 2000;131:871-874.
27. Uckert S, Bazrafshan S, Scheller F, Mayer ME, Jonas U, Stief CG. Functional responses of isolated human seminal vesicle tissue to selective phosphodiesterase inhibitors. Urology 2007;70:185-189.
28. Kriegsfeld LJ, Demas GE, Huang PL, Burnett AL, Nelson RJ. Ejaculatory abnormalities in mice lacking the gene for endothelial nitric oxide synthase (eNOS-/-). Physiol Behav 1999;67:561-566.
29. Hull EM, Lumley LA, Matuszewich L, Dominguez J, Moses J, Lorrain DS. The roles of nitric oxide in sexual function of male rats. Neuropharmacology 1994;33:1499-1504.
30. McMahon CG. Dapoxetine for premature ejaculation. Expert Opin Pharmacother 2010;11:1741-1752.
31. Hoy SM, Scott LJ. Dapoxetine: In premature ejaculation. Drugs 2010;70:1433-1443.
32. Salonia A, Maga T, Colombo R, Scattoni V, Briganti A, Cestari A, Guazzoni G, Rigatti P, Montorsi F. A prospective study comparing paroxetine alone versus paroxetine plus sildenafil in patients with premature ejaculation. J Urol 2002;168:2486-2489.
33. Chen J, Mabjeesh NJ, Matzkin H, Greenstein A. Efficacy of sildenafil as adjuvant therapy to selective serotonin reuptake inhibitor in alleviating premature ejaculation. Urology 2003;61:197-200.
34. Wang WF, Wang Y, Minhas S, Ralph DJ. Can sildenafil treat primary premature ejaculation? A prospective clinical study. Int J Urol 2007;14:331-335.
35. Hosseini MM, Yarmohammadi H. Effect of fluoxetine alone and in combination with sildenafil in patients with premature ejaculation. Urol Int 2007;79:28-32.
36. Weiss P, Brody S. Women's partnered orgasm consistency is associated with greater duration of penile-vaginal intercourse but not of foreplay. J Sex Med 2009;6:135-141.
37. Lee SK, Kim Y, Kim TK, Im GJ, Lee BY, Kim DH, Jin C, Yoo HH. Determination of mirodenafil and sildenafil in the plasma and corpus cavernous of SD male rats. J Pharm Biomed Anal 2009;49:513-518.
38. Lee J, Yoo HH, Rhim KJ, Sohn DR, Kim DH. Metabolism and excretion of 5-ethyl-2-{5-[4-(2-hydroxyethyl)piperazine-1-sulfonyl]-2-propoxyphenyl}-7-propyl-3, 5-dihydropyrrolo[3, 2-d]-pyrimidin-4-one (SK3530) in rats. Rapid Commun Mass Spectrom 2007;21:1139-1149.
39. Hyland R, Roe EG, Jones BC, Smith DA. Identification of the cytochrome P450 enzymes involved in the N-demethylation of sildenafil. Br J Clin Pharmacol 2000;51:239-248.
40. McMahon CG, Althof SE, Kaufman JM, Buvat J, Levine SB, Aquilina JW, Tesfaye F, Rothman M, Rivas DA, Porst H. Efficacy and safety of dapoxetine for the treatment of premature ejaculation: Integrated analysis of results from five phase 3 trials. J Sex Med 2011;8:524-539.
41. Waldinger MD. Toward evidence-based genetic research on lifelong premature ejaculation: A critical evaluation of methodology. Korean J Urol 2011;52:1-8.
42. McMahon CG, Stuckey BG, Andersen M, Purvis K, Koppiker N, Haughie S, Boolell M. Efficacy of sildenafil citrate (Viagra) in men with premature ejaculation. J Sex Med 2005;2:368-375.
43. McMahon C, Kim SW, Park NC, Chang CP, Rivas D, Tesfaye F, Rothman M, Aquilina J. Treatment of premature ejaculation in the Asia-Pacific region: Results from a phase III double-blind, parallel-group study of dapoxetine. J Sex Med 2010;7:256-268.
44. Buvat J, Tesfaye F, Rothman M, Rivas DA, Giuliano F. Dapoxetine for the treatment of premature ejaculation: Results from a randomized, double-blind, placebo-controlled phase 3 trial in 22 countries. Eur Urol 2009;55:957-968.